ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,519,162 | -16.9% | 3,371,132 | +4.4% | 0.00% | 0.0% |
| Q2 2023 | $27,103,174 | +177.1% | 3,230,414 | +228.0% | 0.00% | – |
| Q1 2023 | $9,780,872 | +44.5% | 984,982 | +1.3% | 0.00% | – |
| Q4 2022 | $6,768,154 | +30.7% | 972,436 | +0.2% | 0.00% | – |
| Q3 2022 | $5,180,000 | +33.1% | 970,086 | -0.5% | 0.00% | – |
| Q2 2022 | $3,891,000 | -72.8% | 974,947 | -69.7% | 0.00% | – |
| Q1 2022 | $14,315,000 | +10.8% | 3,220,511 | -0.3% | 0.00% | – |
| Q4 2021 | $12,915,000 | -54.9% | 3,228,811 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $28,658,000 | -22.8% | 3,263,942 | -0.4% | 0.00% | 0.0% |
| Q2 2021 | $37,115,000 | +196.6% | 3,275,784 | +211.0% | 0.00% | – |
| Q1 2021 | $12,514,000 | +133.8% | 1,053,328 | +35.0% | 0.00% | – |
| Q4 2020 | $5,352,000 | -3.8% | 780,304 | +3.9% | 0.00% | – |
| Q3 2020 | $5,565,000 | +176.0% | 751,144 | +55.3% | 0.00% | – |
| Q2 2020 | $2,016,000 | -49.4% | 483,573 | -70.0% | 0.00% | – |
| Q1 2020 | $3,988,000 | -56.7% | 1,614,192 | +1.9% | 0.00% | – |
| Q4 2019 | $9,207,000 | +10.2% | 1,584,625 | -0.1% | 0.00% | – |
| Q3 2019 | $8,357,000 | -9.5% | 1,586,103 | +3.1% | 0.00% | – |
| Q2 2019 | $9,231,000 | -23.8% | 1,538,466 | +14.6% | 0.00% | -100.0% |
| Q1 2019 | $12,117,000 | +12.4% | 1,342,003 | +3.3% | 0.00% | 0.0% |
| Q4 2018 | $10,779,000 | -2.0% | 1,298,715 | +63.0% | 0.00% | – |
| Q3 2018 | $10,996,000 | +77.2% | 796,788 | +2.1% | 0.00% | – |
| Q2 2018 | $6,207,000 | +1997.0% | 780,744 | +1881.2% | 0.00% | – |
| Q1 2018 | $296,000 | +15.6% | 39,407 | +4.5% | 0.00% | – |
| Q4 2017 | $256,000 | -5.5% | 37,694 | +0.1% | 0.00% | – |
| Q3 2017 | $271,000 | +47.3% | 37,667 | -4.7% | 0.00% | – |
| Q2 2017 | $184,000 | +5.1% | 39,544 | +12.7% | 0.00% | – |
| Q1 2017 | $175,000 | – | 35,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |